| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 18158939
[patent_doc_number] => 20230025531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => Novel Isoquinoline Derivative, Preparing Method Thereof, and Pharmaceutical Composition for Preventing or Treating Autophagy Related Diseases Containing the Same as an Active Ingredient
[patent_app_type] => utility
[patent_app_number] => 17/367254
[patent_app_country] => US
[patent_app_date] => 2021-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12514
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17367254
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/367254 | Isoquinoline derivative, preparing method thereof, and pharmaceutical composition for preventing or treating autophagy related diseases containing the same as an active ingredient | Jul 1, 2021 | Issued |
Array
(
[id] => 18565676
[patent_doc_number] => 20230256003
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING SEPSIS CONTAINING FUNCTIONALIZED TRANSITION METAL DICHALCOGENIDE
[patent_app_type] => utility
[patent_app_number] => 18/009665
[patent_app_country] => US
[patent_app_date] => 2021-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8649
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18009665
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/009665 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING SEPSIS CONTAINING FUNCTIONALIZED TRANSITION METAL DICHALCOGENIDE | Jun 23, 2021 | Pending |
Array
(
[id] => 18268208
[patent_doc_number] => 20230089450
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => DISILVER HYDROGEN CITRATE-CONTAINING COMPOSITION, METHOD FOR PRODUCING SAME, ANTIBACTERIAL AGENT OR ANTIVIRAL AGENT USING SAME, AND METHOD FOR PRODUCING SAME
[patent_app_type] => utility
[patent_app_number] => 17/799059
[patent_app_country] => US
[patent_app_date] => 2021-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20342
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17799059
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/799059 | DISILVER HYDROGEN CITRATE-CONTAINING COMPOSITION, METHOD FOR PRODUCING SAME, ANTIBACTERIAL AGENT OR ANTIVIRAL AGENT USING SAME, AND METHOD FOR PRODUCING SAME | Jun 21, 2021 | Pending |
Array
(
[id] => 18707460
[patent_doc_number] => 20230330034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => COVALENTLY CROSS-LINKED GLYCOSYLATED MUCIN NANOPARTICLES AS SYSTEMS FOR THE DELIVERY AND RELEASE OF ACTIVE INGREDIENTS AND BIOMOLECULES
[patent_app_type] => utility
[patent_app_number] => 18/002897
[patent_app_country] => US
[patent_app_date] => 2021-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12687
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18002897
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/002897 | COVALENTLY CROSS-LINKED GLYCOSYLATED MUCIN NANOPARTICLES AS SYSTEMS FOR THE DELIVERY AND RELEASE OF ACTIVE INGREDIENTS AND BIOMOLECULES | Jun 20, 2021 | Pending |
Array
(
[id] => 18550652
[patent_doc_number] => 20230248652
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => BIODEGRADEABLE MULTI-CAVITY MICROPARTICLES AND THEIR USE IN TREATMENT
[patent_app_type] => utility
[patent_app_number] => 18/010219
[patent_app_country] => US
[patent_app_date] => 2021-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13071
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18010219
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/010219 | BIODEGRADEABLE MULTI-CAVITY MICROPARTICLES AND THEIR USE IN TREATMENT | Jun 15, 2021 | Pending |
Array
(
[id] => 18707651
[patent_doc_number] => 20230330230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => SENSITISER FOR CANCER TREATMENT
[patent_app_type] => utility
[patent_app_number] => 18/001843
[patent_app_country] => US
[patent_app_date] => 2021-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10945
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18001843
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/001843 | SENSITISER FOR CANCER TREATMENT | Jun 13, 2021 | Abandoned |
Array
(
[id] => 17183729
[patent_doc_number] => 20210330614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => PROCESS FOR MANUFACTURING PHENYLEPHRINE RESINATE PARTICLES; PHENYLEPHRINE RESINATE PARTICLES; AND USE OF PHENYLEPHRINE RESINATE PARTICLES IN PHARMACEUTICAL FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/343169
[patent_app_country] => US
[patent_app_date] => 2021-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10828
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17343169
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/343169 | PROCESS FOR MANUFACTURING PHENYLEPHRINE RESINATE PARTICLES; PHENYLEPHRINE RESINATE PARTICLES; AND USE OF PHENYLEPHRINE RESINATE PARTICLES IN PHARMACEUTICAL FORMULATIONS | Jun 8, 2021 | Abandoned |
Array
(
[id] => 18436181
[patent_doc_number] => 20230183475
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => GELLING SOLUTIONS FOR ADMINISTRATION OF COMPOUNDS TO THE INNER EAR
[patent_app_type] => utility
[patent_app_number] => 17/923945
[patent_app_country] => US
[patent_app_date] => 2021-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46857
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17923945
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/923945 | GELLING SOLUTIONS FOR ADMINISTRATION OF COMPOUNDS TO THE INNER EAR | May 11, 2021 | Pending |
Array
(
[id] => 19246925
[patent_doc_number] => 20240197909
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => NANOPARTICLES AS CARRIER-SYSTEM FOR ADJUVANTS/ANTIGENS
[patent_app_type] => utility
[patent_app_number] => 17/998318
[patent_app_country] => US
[patent_app_date] => 2021-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15165
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17998318
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/998318 | NANOPARTICLES AS CARRIER-SYSTEM FOR ADJUVANTS/ANTIGENS | May 11, 2021 | Abandoned |
Array
(
[id] => 17719196
[patent_doc_number] => 20220211915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => SURGICAL SYSTEM AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/306053
[patent_app_country] => US
[patent_app_date] => 2021-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20096
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17306053
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/306053 | Surgical system and methods of use | May 2, 2021 | Issued |
Array
(
[id] => 18565731
[patent_doc_number] => 20230256058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => LOW BURST-RELEASE LIRAGLUTIDE DEPOT SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 18/001610
[patent_app_country] => US
[patent_app_date] => 2021-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14300
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18001610
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/001610 | LOW BURST-RELEASE LIRAGLUTIDE DEPOT SYSTEMS | Apr 25, 2021 | Abandoned |
Array
(
[id] => 17911191
[patent_doc_number] => 20220313586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => COSMETIC COMPOSITION WITH GLAUCINE, RETINOL AND PEPTIDES TO COMBAT SKIN AGING
[patent_app_type] => utility
[patent_app_number] => 17/218960
[patent_app_country] => US
[patent_app_date] => 2021-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9960
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17218960
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/218960 | COSMETIC COMPOSITION WITH GLAUCINE, RETINOL AND PEPTIDES TO COMBAT SKIN AGING | Mar 30, 2021 | Abandoned |
Array
(
[id] => 18295913
[patent_doc_number] => 20230105599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => Aqueous Formulations Containing Povidone Iodine for Effective Treatment and Prevention of Virus Infections
[patent_app_type] => utility
[patent_app_number] => 17/281553
[patent_app_country] => US
[patent_app_date] => 2021-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7323
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17281553
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/281553 | Aqueous Formulations Containing Povidone Iodine for Effective Treatment and Prevention of Virus Infections | Mar 28, 2021 | Pending |
Array
(
[id] => 17124265
[patent_doc_number] => 20210299033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => COMPOSITIONS COMPRISING CARUM CARVI AND ROSMARINUS OFFICINALIS EXTRACTS AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/210747
[patent_app_country] => US
[patent_app_date] => 2021-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9802
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17210747
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/210747 | COMPOSITIONS COMPRISING CARUM CARVI AND ROSMARINUS OFFICINALIS EXTRACTS AND METHODS OF USING SAME | Mar 23, 2021 | Abandoned |
Array
(
[id] => 17124271
[patent_doc_number] => 20210299039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASE BY CONTACT LENS MEDIATED DRUG DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/209645
[patent_app_country] => US
[patent_app_date] => 2021-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6228
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17209645
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/209645 | COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASE BY CONTACT LENS MEDIATED DRUG DELIVERY | Mar 22, 2021 | Abandoned |
Array
(
[id] => 17109930
[patent_doc_number] => 20210290527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => Compositions and Methods for Treatment of Ocular Conditions
[patent_app_type] => utility
[patent_app_number] => 17/208381
[patent_app_country] => US
[patent_app_date] => 2021-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5568
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17208381
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/208381 | Compositions and Methods for Treatment of Ocular Conditions | Mar 21, 2021 | Abandoned |
Array
(
[id] => 17213242
[patent_doc_number] => 20210346578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => DEVICE AND METHOD FOR TREATING INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/207337
[patent_app_country] => US
[patent_app_date] => 2021-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4894
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17207337
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/207337 | DEVICE AND METHOD FOR TREATING INFECTIONS | Mar 18, 2021 | Abandoned |
Array
(
[id] => 17124541
[patent_doc_number] => 20210299309
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => TENT WITH ANTIMICROBIAL TREATMENT APPLIED THERETO AND METHOD OF IMPARTING ANTIMICROBIAL PROPERTIES TO THE TENT
[patent_app_type] => utility
[patent_app_number] => 17/205630
[patent_app_country] => US
[patent_app_date] => 2021-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1885
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17205630
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/205630 | TENT WITH ANTIMICROBIAL TREATMENT APPLIED THERETO AND METHOD OF IMPARTING ANTIMICROBIAL PROPERTIES TO THE TENT | Mar 17, 2021 | Abandoned |
Array
(
[id] => 17095266
[patent_doc_number] => 20210283057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => SUSTAINED-RELEASE PARTICLES AND PRODUCTION METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/199518
[patent_app_country] => US
[patent_app_date] => 2021-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23237
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17199518
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/199518 | SUSTAINED-RELEASE PARTICLES AND PRODUCTION METHOD THEREOF | Mar 11, 2021 | Abandoned |
Array
(
[id] => 17095521
[patent_doc_number] => 20210283312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => BIOMIMETIC ELECTRICALLY CONDUCTIVE HYALURONIC ACID-BASED HYDROGELS
[patent_app_type] => utility
[patent_app_number] => 17/198211
[patent_app_country] => US
[patent_app_date] => 2021-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7877
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17198211
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/198211 | Biomimetic electrically conductive hyaluronic acid-based hydrogels | Mar 9, 2021 | Issued |